154 – DTG/3TC Is Noninferior to DTG-Based 3-Drug ART in Children With HIV: D3/Penta 21 Week-96 Results
Background Trials in adults living with HIV have shown non-inferiority of dolutegravir (DTG) plus lamivudine (3TC) 2-drug regimen (DTG/3TC) compared to 3-drug regimens (3DR) for maintaining viral suppression. Data in children are limited. Methods D3 / Penta 21 was a non-inferiority 96-week trial evaluating efficacy and safety of DTG/3TC compared to DTG-based 3DR (control) in…